Literature DB >> 17531077

Isothiocyanate E-4IB induces MAPK activation, delayed cell cycle transition and apoptosis.

J Bodo1, J Duraj, J Jakubikova, J Sedlak.   

Abstract

INTRODUCTION: Epidemiologic studies point towards a significant correlation between the dietary intake of isothiocyanate-containing foods and the reduced risk for cancer. METHODS AND
RESULTS: In the current investigation, we examined the consequence of activating of signalling pathways during the release the cells from the block at G(1)/S boundary by synthetic isothiocyanate E-4IB. Using synchronized leukaemic HL60 cells, we show that activation of mitogen-activated protein kinases ERK1/2, c-Jun N-terminal kinase and p38 signalling pathways by E-4IB are coupled with delayed transition through the cell cycle and rapid cell cycle arrest resulted in diminished mitochondrial membrane potential culminating in apoptosis. These events were accompanied by histone deacetylase inhibition, increase of double strand DNA breaks detected by histone H2AX phosphorylation and up-regulation of cell cycle regulatory protein p21 and phosphorylation of CDC25C phosphatase.
CONCLUSION: These findings suggest that the activation of mitogen-activated protein kinases signalling pathways, followed by the induction cell cycle arrest and apoptosis, might be responsible for anticancer activities of E-4IB.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17531077      PMCID: PMC6496499          DOI: 10.1111/j.1365-2184.2007.00437.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  43 in total

1.  Enhanced sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to the combination of cisplatin and synthetic isothiocyanate ethyl 4-isothiocyanatobutanoate.

Authors:  J Bodo; J Chovancova; L Hunakova; J Sedlak
Journal:  Neoplasma       Date:  2005       Impact factor: 2.575

2.  Histone deacetylase inhibitors, N-butyric acid and trichostatin A, induce caspase-8- but not caspase-9-dependent apoptosis in human malignant glioma cells.

Authors:  T Komata; T Kanzawa; T Nashimoto; H Aoki; S Endo; T Kon; H Takahashi; S Kondo; R Tanaka
Journal:  Int J Oncol       Date:  2005-05       Impact factor: 5.650

3.  Role of PI3K/Akt and MEK/ERK signaling pathways in sulforaphane- and erucin-induced phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2 cells.

Authors:  Jana Jakubíková; Ján Sedlák; Richard Mithen; Yongping Bao
Journal:  Biochem Pharmacol       Date:  2005-04-21       Impact factor: 5.858

4.  Dietary isothiocyanates, glutathione S-transferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore.

Authors:  B Zhao; A Seow; E J Lee; W T Poh; M Teh; P Eng; Y T Wang; W C Tan; M C Yu; H P Lee
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-10       Impact factor: 4.254

5.  Isothiocyanate iberin modulates phase II enzymes, posttranslational modification of histones and inhibits growth of Caco-2 cells by inducing apoptosis.

Authors:  J Jakubikova; Y Bao; J Bodo; J Sedlak
Journal:  Neoplasma       Date:  2006       Impact factor: 2.575

6.  Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization.

Authors:  Steven J T Jackson; Keith W Singletary
Journal:  J Nutr       Date:  2004-09       Impact factor: 4.798

7.  Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C.

Authors:  Shivendra V Singh; Anna Herman-Antosiewicz; Ajita V Singh; Karen L Lew; Sanjay K Srivastava; Ravindra Kamath; Kevin D Brown; Lin Zhang; Rajasekaran Baskaran
Journal:  J Biol Chem       Date:  2004-04-08       Impact factor: 5.157

Review 8.  Cancer-preventive isothiocyanates: measurement of human exposure and mechanism of action.

Authors:  Yuesheng Zhang
Journal:  Mutat Res       Date:  2004-11-02       Impact factor: 2.433

9.  Selected isothiocyanates rapidly induce growth inhibition of cancer cells.

Authors:  Yuesheng Zhang; Li Tang; Veronica Gonzalez
Journal:  Mol Cancer Ther       Date:  2003-10       Impact factor: 6.261

10.  Interactions between sulforaphane and apigenin in the induction of UGT1A1 and GSTA1 in CaCo-2 cells.

Authors:  Vanda Svehlíková; Shuran Wang; Jana Jakubíková; Gary Williamson; Richard Mithen; Yongping Bao
Journal:  Carcinogenesis       Date:  2004-04-16       Impact factor: 4.944

View more
  2 in total

Review 1.  Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.

Authors:  Jiao Zhang; Yan-Hua Chen; Qun Lu
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

2.  Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling.

Authors:  Rana P Singh; Komal Raina; Gagan Deep; Daniel Chan; Rajesh Agarwal
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.